Skip to content
Home/Companies/Healthcare/Ipsophène
Ipsophène

Ipsophène

Healthcare·France·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Ipsophène?

Ipsophène is a French Healthcare company, currently owned by Grand Sud-Ouest Capital since 2019.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Grand Sud-Ouest Capital
Investor
Grand Sud-Ouest Capital
GSO Innovation · 2018 · Growth

Key facts

HQFrance
SectorHealthcare
Websiteipsophene.eu

More from GSO Innovation

Other portfolio companies in the same fund.

iQ Spot
Active
France
Ollow
Active
France
Bohr Energie
Bohr Energie
Active
ClimateTechFrance· 2026
Genoskin
Genoskin
Active
BiotechFrance· 2025
Self & Innov
Self & Innov
Active
FintechFrance· 2024
Ixcys
Ixcys
Active
SoftwareFrance· 2023

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdvaCare
Active
Summit PartnersUS
Advance Health
Active
Summit PartnersUS

Questions

Who owns Ipsophène?

Ipsophène is currently owned by Grand Sud-Ouest Capital, through GSO Innovation, since 2019.

When did Grand Sud-Ouest Capital acquire Ipsophène?

Grand Sud-Ouest Capital acquired Ipsophène in 2019.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue